It was also found that the B cells of COVID-19 patients have increased SHM and higher affinity against the S proteins of HCoVs than that of the pre-pandemic individuals, indicating that SARS-CoV-2 exposure might train the HCoV-induced B cells to produce more effective SARS-CoV-2 NAbs [41]. The gene discussed is PROS1; the disease is COVID-19.